Flexion Therapeutics, Inc. FLXN
$25.14
โฒ +0.32% 24H
About
Flexion Therapeutics, Inc. is an American biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative, locally administered therapies for musculoskeletal conditions. Founded in 2007 and headquartered in Burlington, Massachusetts, Flexion Therapeutics has built its scienโฆ
Sectorโ
ExchangeNASDAQ
Industryโ
CountryUnited States
Employees0
TickerFLXN
Statistics
Market Cap$1.13B
Revenue (TTM)$85.6M
Net Income-$113.7M
Net Margin-132.9%
EPS$-2.53
P/E27.35
P/S0.00
P/B-15.81
EV/EBITDA-1.38
ROE14.5%
Dividend Yield3.02%
Price$25.14
Data: Twelve Data ยท Revenue = mcap / P/S